The Costs They Are a-Rising: Commercialization Costs and the Innovation Process in Drug Development.
Khoshsokhan, Sina. The Costs They Are a-Rising: Commercialization Costs and the Innovation Process in Drug Development. Academy of Management Annual Meeting Proceedings. 2024, Vol. 2024 Issue 1, p1-6.
Artificial intelligence is poised to dramatically reshape the process of developing and approving new medicines, according to ...
Pharmaceutical manufacturing is the industrial-scale process of producing medications through chemical synthesis, biotechnology, or extraction, ensuring both quality and regulatory compliance.
“The idea to process drugs in space isn’t new. Research showing that microgravity can impact crystallization has been done on ...
AI and ML enhance drug discovery by rapidly screening compounds and predicting ADMET properties, reducing resource commitment ...
8don MSN
Some new drugs aren't actually 'new': Pharmaceutical companies exploit patents and raise prices
Pharmaceutical innovation saves lives. But not every "new" drug is truly new.
Companies are moving from using AI for distinct operations to applying the technology for control and optimization of the ...
The various roles for oncology nurses in the conduct of clinical trials were described in a presentation at the 2025 ONS Bridge virtual meeting.
The Costs They Are a-Rising: Commercialization Costs and the Innovation Process in Drug Development.
Commercialization is a crucial phase in the innovation process and its associated costs significantly influence R&D decisions. Yet our understanding of how commercialization costs impact various ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results